are there glp-1 patches Why Don't Deliver—Yet GLP-1 Patches vs. GLP-1 Injections:

Amongst, overweight and obese patients defined by BMI in 2024 (58.9% [95% CIs 53.3-64.2%] female [182/309], median [IQR] age 56.6 [46.2-66.1]) GLP 1RA use has increased from 3.2% (10/309 [95% CIs 1.8-5.9%]) to 13.6% (42/309 [95% CIs 10.2-17.9%] [p=7.1x10-6])

A large retrospective cohort study of 111,646 overweight or obese women found that GLP-1 agonist exposure was associated with lower breast cancer incidence

PHARMACIST FORMULATED FOR GLP-1 USERS Developed by an expert pharmacist, GLPLUS+ is specifically designed for GLP-1 users seeking relief from digestive discomfort, nausea, and bloating

Poll suggests millions want access to GLP1 drugs but are blocked by cost and limited coverage

The 13 states that maintain coverage impose strict restrictions including BMI thresholds over 30, prior authorization requirements, and step therapy mandating patients first try diet, exercise, and cheaper alternatives